Early Death After Chemotherapy as a Quality Indicator-Is It Time to Bench the Benchmark?

JAMA Oncol. 2022 Nov 1;8(11):1559-1560. doi: 10.1001/jamaoncol.2022.1856.

Authors

Catherine Dunn¹, Lucy Gately¹, Peter Gibbs^{1

2}

Affiliations

¹ Personalised Medicine Division, Walter and Eliza Hall Research Institute, Melbourne, Victoria, Australia.
² Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia.

PMID: 35980644
DOI: 10.1001/jamaoncol.2022.1856

No abstract available

Plain language summary

This Viewpoint examines chemotherapy at the end of life as a quality metric.

MeSH terms

Benchmarking*
Humans
Quality Indicators, Health Care*